MADCAM1 and inflammatory bowel disease: Soluble MAdCAM-1 (sMAdCAM-1) levels in serum have been previously associated with gut inflammation occurring during inflammatory bowel disease and have been suggested as a biomarker for tracking effectiveness of therapy (45).